AstraZeneca said Monday that its antiviral drug was shown to be effective at neutralizing the COVID-19 omicron variant, including the newer BA.2 variant that is causing cases to rise in Europe and Asia.
Now that CDC recognizes the protective effect of prior infection, it is time to update vaccination policies and school or work-entry requirements across federal and state or county governments.